Bilateral Peribulbar Block for Cataract Surgery

NCT ID: NCT07000669

Last Updated: 2025-06-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-06-03

Study Completion Date

2025-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the safety and efficacy of bilateral peribulbar block for cataract surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cataract surgery is one of the most commonly performed procedures worldwide, with local anesthesia being the preferred method due to its safety, efficacy, and cost-effectiveness.

Peribulbar anaesthesia has gained popularity due to its relative efficacy in generating ocular akinesia and anaesthesia with a reduced risk of consequences such as optic nerve damage and globe perforation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Safety Efficacy Bilateral Peribulbar Block Cataract Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Peribulbar anesthesia group

Patients undergoing bilateral peribulbar anesthesia for cataract surgery

Bilateral peribulbar block

Intervention Type OTHER

Patients undergoing bilateral peribulbar anesthesia for cataract surgery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bilateral peribulbar block

Patients undergoing bilateral peribulbar anesthesia for cataract surgery.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years.
* Both sexes.
* American Society of Anesthesiology (ASA) physical status I-III.
* Patients undergoing cataract surgery

Exclusion Criteria

* Infection at the site of the surgery.
* Allergy to any of the used drugs.
* Coagulopathy.
* Posterior staphyloma.
* Bronchial asthma.
* Bradyarrhythmia.
* Pre-existing ocular muscle paresis.
* Neurological deficit.
* Co-existing inflammatory conditions of eye.
* Complicated cataracts.
* Previously operated eyes.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tanta University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed Ibrahim Elshahawy

Consultant Anesthesiology, MAGRABI Hospital and Centers, Kingdom of Saudi Arabia

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tanta University

Tanta, El-Gharbia, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed I Elshahawy, MD

Role: CONTACT

00966568458735

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ahmed I Elshahawy, MD

Role: primary

00966568458735

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

36264PR1192/4/25.

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.